Ken Griffin 10x Genomics, Inc. Put Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$15.71 - $23.49 $152,387 - $227,852	9,700 Added 52.43%	28,200 $636,000
Q2 2024 Aug 14, 2024	BUY	$19.45 - $37.37 $167,270 - $321,382	8,600 Added 86.87%	18,500 $359,000
Q1 2024 May 15, 2024	SELL	$36.08 - $54.3 $858,704 - $1.29 Million	-23,800 Reduced 70.62%	9,900 $371,000
Q4 2023 Feb 14, 2024	SELL	$34.32 - $57.55 $415,272 - $696,355	-12,100 Reduced 26.42%	33,700 $1.89 Million
Q3 2023 Nov 14, 2023	BUY	$40.86 - $62.98 $661,932 - $1.02 Million	16,200 Added 54.73%	45,800 $1.89 Million
Q2 2023 Aug 14, 2023	SELL	$50.96 - $58.72 $2.13 Million - $2.45 Million	-41,700 Reduced 58.49%	29,600 $1.65 Million
Q1 2023 May 15, 2023	BUY	$35.33 - $55.79 $1.78 Million - $2.81 Million	50,400 Added 241.15%	71,300 $3.98 Million
Q4 2022 Feb 14, 2023	SELL	$24.4 - $41.3 $90,280 - $152,810	-3,700 Reduced 15.04%	20,900 $761,000
Q3 2022 Nov 14, 2022	SELL	$28.48 - $52.59 $1.09 Million - $2 Million	-38,100 Reduced 60.77%	24,600 $701,000

291

94.7M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.33B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.